Cargando…
Cost-effectiveness of antiviral therapy during late pregnancy to prevent perinatal transmission of hepatitis B virus
Background. Hepatitis B virus (HBV) infections are perinatally transmitted from chronically infected mothers. Supplemental antiviral therapy during late pregnancy with lamivudine (LAM), telbivudine (LdT), or tenofovir (TDF) can substantially reduce perinatal HBV transmission compared to postnatal im...
Autores principales: | Wang, Wenjun, Wang, Jingjing, Dang, Shuangsuo, Zhuang, Guihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811175/ https://www.ncbi.nlm.nih.gov/pubmed/27042389 http://dx.doi.org/10.7717/peerj.1709 |
Ejemplares similares
-
Cost-effectiveness of antiviral prophylaxis during pregnancy for the prevention of perinatal hepatitis B infection in South Korea
por: Lee, Donghoon, et al.
Publicado: (2018) -
Expanding Antiviral Prophylaxis During Pregnancy to Prevent Perinatal Hepatitis B Virus Infection: A Cost-effectiveness Study
por: Du, Jiangyang, et al.
Publicado: (2020) -
Estimating the costs of the national basic public health services in Zhuhai, China, through activity-based costing: a cross-sectional study
por: Wang, Zan, et al.
Publicado: (2019) -
Antiviral Therapy for Prevention of Perinatal Hepatitis B Virus Transmission Reduces the Incidence of Postpartum Hepatitis Flare
por: Quan, Min, et al.
Publicado: (2022) -
Cost-effectiveness of Atezolizumab Plus Bevacizumab vs Sorafenib for Patients
With Unresectable or Metastatic Hepatocellular Carcinoma
por: Zhang, Xin, et al.
Publicado: (2021)